Humacyte Inc
NASDAQ:HUMA

Watchlist Manager
Humacyte Inc Logo
Humacyte Inc
NASDAQ:HUMA
Watchlist
Price: 2.28 USD -1.3% Market Closed
Market Cap: 353.7m USD

Wall Street
Price Targets

HUMA Price Targets Summary
Humacyte Inc

Wall Street analysts forecast HUMA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HUMA is 9.62 USD with a low forecast of 3.03 USD and a high forecast of 26.25 USD.

Lowest
Price Target
3.03 USD
33% Upside
Average
Price Target
9.62 USD
322% Upside
Highest
Price Target
26.25 USD
1 051% Upside
Humacyte Inc Competitors:
Price Targets
300676
BGI Genomics Co Ltd
8% Upside
005690
Pharmicell Co Ltd
45% Upside
2696
Shanghai Henlius Biotech Inc
36% Downside
MIRM
Mirum Pharmaceuticals Inc
43% Upside
IMMX
Immix Biopharma Inc
180% Upside
BMRN
Biomarin Pharmaceutical Inc
70% Upside
AGIO
Agios Pharmaceuticals Inc
53% Upside
PRQR
ProQR Therapeutics NV
321% Upside

Revenue
Forecast

Revenue Estimate
Humacyte Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Humacyte Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Humacyte Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-76%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HUMA's stock price target?
Price Target
9.62 USD

According to Wall Street analysts, the average 1-year price target for HUMA is 9.62 USD with a low forecast of 3.03 USD and a high forecast of 26.25 USD.

Back to Top